SENSICARDIAC vs LINQ II Insertable Cardiac Monitor

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 65/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.

SENSICARDIAC

by Diacoustic Medical Devices (Pty) Ltd.

LINQ II Insertable Cardiac Monitor

by Medtronic

AI Verdict

SENSICARDIAC is an AI-powered, cloud-based service for real-time heart murmur detection and classification using electronic stethoscopes, ideal for diagnostic screening and reducing unnecessary referrals. The LINQ II, conversely, is an insertable cardiac monitor offering long-term, continuous AI-powered monitoring for arrhythmias. While both leverage AI in cardiology, they address distinct diagnostic needs—murmurs versus heart rhythms—and employ vastly different methodologies for data acquisition and monitoring duration.

Choose SENSICARDIAC if…

Choose SENSICARDIAC if your practice requires an immediate, AI-powered diagnostic aid for heart murmur detection during patient examinations. This cloud-based service integrates with electronic stethoscopes to provide real-time classification of murmurs, helping to streamline diagnoses and reduce unnecessary specialist referrals. It's ideal for primary care, internal medicine, and pediatric settings needing efficient, point-of-care cardiac screening.

View SENSICARDIAC →

Choose LINQ II Insertable Cardiac Monitor if…

Choose the LINQ II Insertable Cardiac Monitor if your patients require long-term, continuous heart rhythm monitoring for the diagnosis of infrequent or elusive arrhythmias. This subcutaneous device offers up to 4.5 years of monitoring with AI-powered accuracy and remote management capabilities, making it suitable for patients needing extended surveillance beyond what a standard external monitor can provide. It's particularly beneficial for identifying intermittent cardiac events that might otherwise go undetected.

View LINQ II Insertable Cardiac Monitor →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature	SENSICARDIAC	LINQ II Insertable Cardiac Monitor
Deployment	SensiCardiac is a software package running on a Windows PC that interfaces with compatible electronic stethoscopes. SensiCardiac Mobi runs on a mobile device (iPhone 4S or later) and interfaces with a hosted Linux server environment. The related Telesensi platform operates entirely in the browser.	Subcutaneous implant with remote monitoring via mobile app or home communicator.
FDA Status	Cleared AI-estimated	Cleared AI-estimated
HIPAA	Yes AI-estimated	Unknown

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

SENSICARDIAC

SENSICARDIAC offers a guided auscultation process and real-time analysis directly integrated into the physician's examination workflow, making it highly usable for immediate diagnostic support. LINQ II's usability for clinicians is more focused on remote management and data review of an implanted device, which is a different interaction model.

Clinical Value

LINQ II Insertable Cardiac Monitor

While SENSICARDIAC provides valuable real-time diagnostic aid for heart murmurs, LINQ II offers long-term, continuous monitoring for arrhythmias over several years (up to 4.5 years), including a pediatric indication. This extended, continuous data collection and AI-powered arrhythmia detection provide a more comprehensive and potentially life-saving clinical value for detecting intermittent and critical cardiac events.

Pricing & Value

Tie

Both tools lack public pricing transparency, stating that pricing is either by contact or negotiated with healthcare systems. Without specific pricing details or comparative value propositions, it is impossible to determine a winner in this dimension.

Enterprise Readiness

LINQ II Insertable Cardiac Monitor

Medtronic's LINQ II has a proven track record of deployment to over a million patients worldwide and is explicitly targeted at health systems of all sizes, demonstrating robust enterprise readiness and scalability. SENSICARDIAC, while cloud-based and HIPAA compliant, does not provide comparable evidence of large-scale enterprise adoption.

Innovation

LINQ II Insertable Cardiac Monitor

While SENSICARDIAC offers innovative real-time AI-powered murmur detection, LINQ II's combination of long-term (up to 4.5 years) continuous monitoring, AI-enhanced arrhythmia detection (AccuRhythmu2122), remote programming for an implantable device, MRI compatibility, and specific advanced algorithms like innovative PVC detection represents a more significant and multifaceted innovation in cardiac care technology.

Support & Docs

LINQ II Insertable Cardiac Monitor

Medtronic provides a significantly more extensive and accessible support and documentation ecosystem for LINQ II, including multiple contact channels, dedicated technical and patient support specialists, and a wealth of online resources for both clinicians and patients. SENSICARDIAC primarily offers user manuals for its software.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature	SENSICARDIAC	LINQ II Insertable Cardiac Monitor
Tool Name	SENSICARDIAC	LINQ II Insertable Cardiac Monitor
Company	DIACOUSTIC MEDICAL (PTY)	Medtronic
Primary Function	AI-powered, cloud-based heart murmur detection service that integrates with electronic stethoscopes to classify murmurs as pathological or physiological.	Advanced, AI-powered insertable cardiac monitor providing long-term, continuous heart rhythm monitoring for diagnosing arrhythmias.
Key AI Functionality	AI-powered heart murmur detection, classification of murmurs (Class I: dangerous pathological, Class III: innocent physiological).	AccuRhythmu2122 AI algorithms for enhanced accuracy, innovative PVC detection algorithm.
Monitoring/Detection Method	Integration with electronic stethoscopes for real-time analysis and guided auscultation.	Insertable cardiac monitor providing up to 4.5 years of continuous monitoring.
Target Specialties	Cardiology, Internal Medicine, Pediatrics	Cardiology

Videos

Demos, reviews, and walkthroughs featuring SENSICARDIAC and LINQ II Insertable Cardiac Monitor.

Loading videos…

Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

How does each tool integrate into a physician's existing clinical workflow and what specific clinical scenarios are they best suited for?

SENSICARDIAC is designed for real-time heart murmur detection during auscultation, integrating with electronic stethoscopes to classify murmurs as pathological or physiological and generating detailed cardiac reports. It aids in immediate diagnostic support and reducing unnecessary referrals for murmurs. LINQ II, conversely, is an insertable cardiac monitor providing long-term, continuous heart rhythm monitoring for diagnosing arrhythmias, ideal for patients with infrequent symptoms requiring extended observation.

What is the depth of EHR integration for each tool, particularly regarding automated data flow and accessibility within patient records?

SENSICARDIAC generates downloadable PDF cardiac reports, suggesting a more manual process for EHR integration. LINQ II offers 'data export' and integrates with the Medtronic CareLinku2122 Network, which supports secure, two-way communication and remote programming, potentially reducing office visits and streamlining data review within existing clinical workflows.

Can you elaborate on the real-world accuracy and sensitivity of each tool's AI algorithms in detecting their respective cardiac conditions?

SENSICARDIAC's AI-powered murmur detection analyzes recordings against a large validated database of pathological heart murmurs, classifying them as Class I (dangerous pathological) or Class III (innocent physiological). LINQ II utilizes AccuRhythmu2122 AI algorithms, which have demonstrated a significant reduction in false AF and Pause alerts (e.g., 88.2% reduction in false AF alerts and 97.4% reduction in false Pause alerts), while preserving true alerts (e.g., 99% true AF alerts preserved and 100% true Pause alerts preserved), enhancing accuracy for arrhythmia diagnosis.

What is the typical learning curve for physicians and their support staff to effectively utilize each tool, from initial setup to routine operation and data interpretation?

SENSICARDIAC features a 'guided auscultation process' to simplify its use, suggesting a relatively straightforward learning curve for operating the device and interpreting its real-time analysis and reports. For LINQ II, Medtronic provides educational resources through Medtronic Academy, including learning plans for device insertion and managing patients on the CareLink Network, indicating a structured training process for both initial setup and ongoing patient management.

What kind of ongoing technical support, clinical training, and educational resources are provided to ensure optimal use and troubleshooting for each system?

For SENSICARDIAC, the provided information mentions user manuals and setup guides, implying basic support and documentation. Medtronic offers comprehensive support for LINQ II through the Medtronic Academy, providing learning plans, courses, videos, and quizzes for clinicians on device insertion, follow-up, and managing patients on the CareLink Network.

For larger practices or health systems, what considerations should be made for deploying each tool across multiple sites, and how does each solution support scalability?

LINQ II is designed for scalability, with Medtronic stating its target size ranges from 'Solo to large health systems' and having over 1 million patients worldwide, implying robust infrastructure for multi-site deployments and remote patient management. SENSICARDIAC is a cloud-based service, which inherently supports remote access and could be scalable, but specific multi-site deployment considerations are not detailed in the provided information.